Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Apelian David
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
No purchase track record
73%
Avg. Sale Return
31%
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
--
--
--
--
--
Purchase Success Rate
--
--
--
--
--
Average Sale Return
36%
28%
29%
61%
73%
Sale Success Rate
1 of 1
1 of 1
1 of 1
1 of 1
1 of 1
Eiger BioPharmaceuticals, I...
Drugs
» Biotechnology
CEO, Director:
Holdings:
11.0K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--
Achillion Pharmaceuticals, ...
Drugs
» Biotechnology
Chief Medical Officer:
Holdings: 0 shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--